icd10free.comPowered by Curo

ICD-10 Coding for Cost-Effectiveness Analysis(R97.0, C18.0, R79.89)

Save

Learn about the ICD-10 coding and documentation requirements for cost-effectiveness analysis, including elevated CEA levels and related clinical contexts.

Also known as:
CEAEconomic Evaluation
Related ICD-10 Code Ranges

Complete code families applicable to Cost-Effectiveness Analysis

R00-R99Primary Range

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

→
Primary ICD-10-CM Codes
Elevated carcinoembryonic antigen [CEA]
R97.0Billable
Differential Codes

Alternative codes to consider when ruling out similar conditions

Other specified abnormal findings of blood chemistryR79.89

Use when other blood markers are abnormal but CEA is normal.

Documentation & Coding Risks

Avoid these common issues when documenting Cost-Effectiveness Analysis.

Failing to document CEA level.

Impact

Clinical: Inaccurate clinical assessment., Regulatory: Non-compliance with documentation standards., Financial: Potential revenue loss due to incorrect coding.

Mitigation

Use templates to ensure complete documentation., Educate staff on documentation requirements.

Using R97.0 without specifying CEA level.

Impact

Reimbursement: May lead to incorrect DRG assignment., Compliance: Non-compliance with coding guidelines., Data Quality: Poor data quality and inaccurate clinical records.

Mitigation

Document the exact CEA level and clinical context.

Documentation Completeness

Impact

Incomplete documentation of CEA levels.

Mitigation

Implement mandatory fields in EHR for CEA documentation.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with R97.0.